These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 8012702)

  • 1. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
    Hecker M; Pörsti I; Bara AT; Busse R
    Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelium-derived bradykinin in the control of vascular tone.
    Hecker M; Dambacher T; Busse R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
    Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
    Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the biological efficacy of bradykinin by ACE inhibitors: a shift in the affinity of the B2 receptor?
    Hecker M; Bara AT; Busse R
    Immunopharmacology; 1996 Jun; 33(1-3):93-4. PubMed ID: 8856122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
    Busse R; Fleming I; Hecker M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation.
    Bauersachs J; Hecker M; Busse R
    Br J Pharmacol; 1994 Dec; 113(4):1548-53. PubMed ID: 7889312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
    Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
    Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: role of endothelium-derived kinins.
    Hecker M; Bara AT; Busse R
    J Vasc Res; 1993; 30(5):257-62. PubMed ID: 8399986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
    Hecker M; Bara AT; Busse R
    Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation.
    Dendorfer A; Reibetamann S; Wolfrum S; Raasch W; Dominiak P
    Hypertension; 2001 Jul; 38(1):142-6. PubMed ID: 11463775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the vascular response to kinins by inhibition of myocardial kininases.
    Dendorfer A; Wolfrum S; Schäfer U; Stewart JM; Inamura N; Dominiak P
    Hypertension; 2000 Jan; 35(1 Pt 1):32-7. PubMed ID: 10642271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals.
    Hecker M; Bara AT; Bauersachs J; Busse R
    J Physiol; 1994 Dec; 481 ( Pt 2)(Pt 2):407-14. PubMed ID: 7738833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
    Hecker M; Benzing T; Busse R
    Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
    Tom B; de Vries R; Saxena PR; Danser AH
    Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: modulation of contractile response to bradykinin.
    Gobeil F; Hallé S; Blais PA; Regoli D
    Can J Physiol Pharmacol; 2002 Feb; 80(2):153-63. PubMed ID: 11934258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed.
    Lamontagne D; König A; Bassenge E; Busse R
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):652-7. PubMed ID: 1280723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
    Wiemer G; Popp R; Schölkens BA; Gögelein H
    Brain Res; 1994 Feb; 638(1-2):261-6. PubMed ID: 7515323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibitor and AT1 antagonist blockade of deformation-induced gene expression in the rabbit jugular vein through B2 receptor activation.
    Lauth M; Cattaruzza M; Hecker M
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):61-6. PubMed ID: 11145934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-derived hyperpolarizing factor, but not nitric oxide or prostacyclin release, is resistant to menadione-induced oxidative stress in the bovine coronary artery.
    Kaw S; Hecker M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Feb; 359(2):133-9. PubMed ID: 10048598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.